REDUCE LAP-HF II interatrial shunt trial: neutral, but necessary.

Kapur, Navin K, Jenica N Upshaw, and Benjamin S Wessler. 2022. “REDUCE LAP-HF II Interatrial Shunt Trial: Neutral, But Necessary.”. Lancet (London, England) 399 (10330): 1094-95.